Loading…

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Abstract The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scient...

Full description

Saved in:
Bibliographic Details
Published in:Medical cannabis and cannabinoids 2022-10, Vol.5 (1), p.138-141
Main Authors: Smolinski, Nicole E., Sajdeya, Ruba, Cook, Robert, Wang, Yan, Winterstein, Almut G., Goodin, Amie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4470-fc8e4c0867bb473b60f09dc30c3e223c2546172d5efc737b67757cc283a0f9763
container_end_page 141
container_issue 1
container_start_page 138
container_title Medical cannabis and cannabinoids
container_volume 5
creator Smolinski, Nicole E.
Sajdeya, Ruba
Cook, Robert
Wang, Yan
Winterstein, Almut G.
Goodin, Amie
description Abstract The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.
doi_str_mv 10.1159/000527080
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9710315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9026b065d07749139d0b2517399961b3</doaj_id><sourcerecordid>2747006603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4470-fc8e4c0867bb473b60f09dc30c3e223c2546172d5efc737b67757cc283a0f9763</originalsourceid><addsrcrecordid>eNptkcFrFTEQh4MottQevHtY8KKHZyfJJtlchLK0WmhpKXoOSXbyXuq-5JnsE_zv3brlYcHThPl9fDNhCHlL4ROlQp8BgGAKOnhBjpmAdsW7Tr_8531ETmt9mDFGW1C8e02OuGylUh07Jpd3JXvEIaZ1bXJopg02DBhrepuSdbE2_RhT9HZsbveTz1uszT1WtMVvmj6ngAWTxzfkVbBjxdOnekK-X15867-urm-_XPXn1yvftgpWwXfYeuikcq5V3EkIoAfPwXNkjHsmWkkVGwQGr7hy85JCec86biFoJfkJuVq8Q7YPZlfi1pbfJtto_jZyWRtbpuhHNBqYdCDFAEq1mnI9gGOCKq61ltTx2fV5ce32bouDxzQVOz6TPk9S3Jh1_mW0osCpmAUfngQl_9xjncw2Vo_jaBPmfTVMzX8GKeFx1scF9SXXWjAcxlAwj2c0hzPO7LuF_WHLGsuBPMTv_xvf9OcLYXZD4H8AW7SfNA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2747006603</pqid></control><display><type>article</type><title>Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference</title><source>PubMed Central</source><source>Karger Open Access</source><creator>Smolinski, Nicole E. ; Sajdeya, Ruba ; Cook, Robert ; Wang, Yan ; Winterstein, Almut G. ; Goodin, Amie</creator><creatorcontrib>Smolinski, Nicole E. ; Sajdeya, Ruba ; Cook, Robert ; Wang, Yan ; Winterstein, Almut G. ; Goodin, Amie</creatorcontrib><description>Abstract The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.</description><identifier>ISSN: 2504-3889</identifier><identifier>EISSN: 2504-3889</identifier><identifier>DOI: 10.1159/000527080</identifier><identifier>PMID: 36467782</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>cannabidiol ; cannabinoids ; cannabis ; cannabis clinical outcomes research conference ; marijuana clinical outcomes ; marijuana efficacy ; medical marijuana ; Meeting Report</subject><ispartof>Medical cannabis and cannabinoids, 2022-10, Vol.5 (1), p.138-141</ispartof><rights>2022 The Author(s). Published by S. Karger AG, Basel</rights><rights>Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4470-fc8e4c0867bb473b60f09dc30c3e223c2546172d5efc737b67757cc283a0f9763</cites><orcidid>0000-0002-0866-4579 ; 0000-0002-6518-5961 ; 0000-0002-1101-3603 ; 0000-0002-0020-8720</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710315/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710315/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27635,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Smolinski, Nicole E.</creatorcontrib><creatorcontrib>Sajdeya, Ruba</creatorcontrib><creatorcontrib>Cook, Robert</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Winterstein, Almut G.</creatorcontrib><creatorcontrib>Goodin, Amie</creatorcontrib><title>Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference</title><title>Medical cannabis and cannabinoids</title><addtitle>Med Cannabis Cannabinoids</addtitle><description>Abstract The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.</description><subject>cannabidiol</subject><subject>cannabinoids</subject><subject>cannabis</subject><subject>cannabis clinical outcomes research conference</subject><subject>marijuana clinical outcomes</subject><subject>marijuana efficacy</subject><subject>medical marijuana</subject><subject>Meeting Report</subject><issn>2504-3889</issn><issn>2504-3889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>DOA</sourceid><recordid>eNptkcFrFTEQh4MottQevHtY8KKHZyfJJtlchLK0WmhpKXoOSXbyXuq-5JnsE_zv3brlYcHThPl9fDNhCHlL4ROlQp8BgGAKOnhBjpmAdsW7Tr_8531ETmt9mDFGW1C8e02OuGylUh07Jpd3JXvEIaZ1bXJopg02DBhrepuSdbE2_RhT9HZsbveTz1uszT1WtMVvmj6ngAWTxzfkVbBjxdOnekK-X15867-urm-_XPXn1yvftgpWwXfYeuikcq5V3EkIoAfPwXNkjHsmWkkVGwQGr7hy85JCec86biFoJfkJuVq8Q7YPZlfi1pbfJtto_jZyWRtbpuhHNBqYdCDFAEq1mnI9gGOCKq61ltTx2fV5ce32bouDxzQVOz6TPk9S3Jh1_mW0osCpmAUfngQl_9xjncw2Vo_jaBPmfTVMzX8GKeFx1scF9SXXWjAcxlAwj2c0hzPO7LuF_WHLGsuBPMTv_xvf9OcLYXZD4H8AW7SfNA</recordid><startdate>20221017</startdate><enddate>20221017</enddate><creator>Smolinski, Nicole E.</creator><creator>Sajdeya, Ruba</creator><creator>Cook, Robert</creator><creator>Wang, Yan</creator><creator>Winterstein, Almut G.</creator><creator>Goodin, Amie</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0866-4579</orcidid><orcidid>https://orcid.org/0000-0002-6518-5961</orcidid><orcidid>https://orcid.org/0000-0002-1101-3603</orcidid><orcidid>https://orcid.org/0000-0002-0020-8720</orcidid></search><sort><creationdate>20221017</creationdate><title>Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference</title><author>Smolinski, Nicole E. ; Sajdeya, Ruba ; Cook, Robert ; Wang, Yan ; Winterstein, Almut G. ; Goodin, Amie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4470-fc8e4c0867bb473b60f09dc30c3e223c2546172d5efc737b67757cc283a0f9763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cannabidiol</topic><topic>cannabinoids</topic><topic>cannabis</topic><topic>cannabis clinical outcomes research conference</topic><topic>marijuana clinical outcomes</topic><topic>marijuana efficacy</topic><topic>medical marijuana</topic><topic>Meeting Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smolinski, Nicole E.</creatorcontrib><creatorcontrib>Sajdeya, Ruba</creatorcontrib><creatorcontrib>Cook, Robert</creatorcontrib><creatorcontrib>Wang, Yan</creatorcontrib><creatorcontrib>Winterstein, Almut G.</creatorcontrib><creatorcontrib>Goodin, Amie</creatorcontrib><collection>Karger Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Medical cannabis and cannabinoids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smolinski, Nicole E.</au><au>Sajdeya, Ruba</au><au>Cook, Robert</au><au>Wang, Yan</au><au>Winterstein, Almut G.</au><au>Goodin, Amie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference</atitle><jtitle>Medical cannabis and cannabinoids</jtitle><addtitle>Med Cannabis Cannabinoids</addtitle><date>2022-10-17</date><risdate>2022</risdate><volume>5</volume><issue>1</issue><spage>138</spage><epage>141</epage><pages>138-141</pages><issn>2504-3889</issn><eissn>2504-3889</eissn><abstract>Abstract The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>36467782</pmid><doi>10.1159/000527080</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-0866-4579</orcidid><orcidid>https://orcid.org/0000-0002-6518-5961</orcidid><orcidid>https://orcid.org/0000-0002-1101-3603</orcidid><orcidid>https://orcid.org/0000-0002-0020-8720</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2504-3889
ispartof Medical cannabis and cannabinoids, 2022-10, Vol.5 (1), p.138-141
issn 2504-3889
2504-3889
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9710315
source PubMed Central; Karger Open Access
subjects cannabidiol
cannabinoids
cannabis
cannabis clinical outcomes research conference
marijuana clinical outcomes
marijuana efficacy
medical marijuana
Meeting Report
title Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A26%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proceedings%20of%20the%202022%20Cannabis%20Clinical%20Outcomes%20Research%20Conference&rft.jtitle=Medical%20cannabis%20and%20cannabinoids&rft.au=Smolinski,%20Nicole%20E.&rft.date=2022-10-17&rft.volume=5&rft.issue=1&rft.spage=138&rft.epage=141&rft.pages=138-141&rft.issn=2504-3889&rft.eissn=2504-3889&rft_id=info:doi/10.1159/000527080&rft_dat=%3Cproquest_pubme%3E2747006603%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4470-fc8e4c0867bb473b60f09dc30c3e223c2546172d5efc737b67757cc283a0f9763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2747006603&rft_id=info:pmid/36467782&rfr_iscdi=true